Analyst stock forecast
Climb Bio Forecast: $27.87 Analyst Target
Direct answer
Climb Bio's average price target is $27.87.
The target implies +191.2% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +88.1%, the high target implies +318%, and the range spans 229.9% of the current price.
Forecast evidence checked October 27, 2026.
Get free Climb Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.57
- Average price target
- $27.87
- High price target
- $40.00
- Low price target
- $18.00
- Low target gap
- +88.1%
- Target upside
- +191.2%
- High target gap
- +318%
- Target range width
- 229.9%
- Consensus rating
- Strong Buy
- Analysts
- 15
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
What is Climb Bio's average price target?
Climb Bio's verified average price target is $27.87. The target range is $18.00 to $40.00.
How far are Climb Bio's low and high targets from the recorded price?
The low target implies +88.1%, while the high target implies +318%.
How many analysts are included in Climb Bio's consensus?
The verified consensus includes 15 analysts.
How is Climb Bio's target upside or downside calculated?
The average target of $27.87 is divided by the recorded price of $9.57, then one is subtracted to produce +191.2%. This does not guarantee a future return.
When was Climb Bio's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.